Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22294344 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention: Drug: anakinra

Study has passed its completion date and status has not been verified in more than two years.